Redeye continues to see an interesting long term investment case. Scibase’s Q2 results were generally in line, albeit with a slightly lower sales number than expected. The item that stood out most in the quarter was the record-strong gross margin. We leave our Base case unchanged at SEK 12 per share.
LÄS MER